Epithelial ovarian cancer

S Lheureux, C Gourley, I Vergote, AM Oza - The Lancet, 2019 - thelancet.com
Epithelial ovarian cancer generally presents at an advanced stage and is the most common
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …

Ovarian cancer in the world: epidemiology and risk factors

Z Momenimovahed, A Tiznobaik, S Taheri… - … journal of women's …, 2019 - Taylor & Francis
Aim: Ovarian cancer is one of the most common gynecologic cancers that has the highest
mortality rate. Considering the fact that knowledge on the incidence, mortality of ovarian …

Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline

PA Konstantinopoulos, B Norquist… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide recommendations on genetic and tumor testing for women diagnosed
with epithelial ovarian cancer based on available evidence and expert consensus …

Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women

AW Kurian, E Hughes, EA Handorf, A Gutin… - JCO Precision …, 2017 - ascopubs.org
Purpose Multiple-gene, next-generation sequencing panels are increasingly used to assess
hereditary cancer risks of patients with diverse personal and family cancer histories. The …

Ovarian cancer in the era of immune checkpoint inhibitors: state of the art and future perspectives

BA Maiorano, MFP Maiorano, D Lorusso, E Maiello - Cancers, 2021 - mdpi.com
Simple Summary Ovarian cancer (OC) represents the fifth leading cause of cancer-related
deaths among women. In the advanced disease setting, OC recurrence after chemotherapy …

Diagnosis of Lynch syndrome and strategies to distinguish Lynch-related tumors from sporadic MSI/dMMR tumors

J Leclerc, C Vermaut, MP Buisine - Cancers, 2021 - mdpi.com
Simple Summary Microsatellite instability (MSI) is a hallmark of Lynch syndrome (LS)-related
tumors but is not specific, as most of MSI/mismatch repair-deficient (dMMR) tumors are …

Genomics to immunotherapy of ovarian clear cell carcinoma: unique opportunities for management

K Oda, J Hamanishi, K Matsuo, K Hasegawa - Gynecologic oncology, 2018 - Elsevier
Ovarian clear cell carcinoma (OCCC) is distinctive from other histological types of epithelial
ovarian cancer, with genetic/epigenetic alterations, a specific immune-related molecular …

Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

O Ceyhan-Birsoy, G Jayakumaran, Y Kemel… - Genome Medicine, 2022 - Springer
Background Genetic testing (GT) for hereditary cancer predisposition is traditionally
performed on selected genes based on established guidelines for each cancer type …

[HTML][HTML] The epigenetic correlation among ovarian cancer, endometriosis and PCOS: A review

HT PK, L Unnikrishnan, M Pangath… - Critical reviews in …, 2022 - Elsevier
Ovarian cancer is a frequent malignancy that affects a large percentage of women.
Endometriosis is a chronic condition, where there is a production of benign lesions were …

Mismatch repair deficiency in ovarian carcinoma: frequency, causes, and consequences

S Leskela, I Romero, E Cristobal… - The American Journal …, 2020 - journals.lww.com
Mismatch repair deficiency (MMRD) is involved in the initiation of both hereditary and
sporadic tumors. MMRD has been extensively studied in colorectal cancer and endometrial …